The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss
- DOI
- 10.1016/j.expneurol.2019.05.002
- Published
- 2019-08
- Container
- Experimental Neurology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.expneurol.2019.05.002,
title = {The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss},
author = {Elizabeth M. Kline and Laura M. Butkovich and Joshua M. Bradner and Jianjun Chang and Harris Gelbard and Val Goodfellow and W. Michael Caudle and Malú G. Tansey},
year = {2019},
journal = {Experimental Neurology},
doi = {10.1016/j.expneurol.2019.05.002},
url = {https://doi.org/10.1016/j.expneurol.2019.05.002}
}RIS
TY - JOUR TI - The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss AU - Elizabeth M. Kline AU - Laura M. Butkovich AU - Joshua M. Bradner AU - Jianjun Chang AU - Harris Gelbard AU - Val Goodfellow AU - W. Michael Caudle AU - Malú G. Tansey PY - 2019 JO - Experimental Neurology DO - 10.1016/j.expneurol.2019.05.002 UR - https://doi.org/10.1016/j.expneurol.2019.05.002 ER -
APA
Kline, E. M., Butkovich, L. M., Bradner, J. M., Chang, J., Gelbard, H., Goodfellow, V., Caudle, W. M., & Tansey, M. G. (2019). The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2019.05.002
Source records
- crossref · retrieved 2026-09-26T18:02:13.777Z